CSPC PHARMACEUTICAL GROUP LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.16 USD | +1.61% |
|
-1.19% | -14.36% |
| 06-28 | CSPC Pharmaceutical Group Limited Announces Enlonstobart Injection Obtains Conditional Marketing Approval | CI |
| 06-28 | CSPC Pharma's Breast Cancer Drug Gets Approval in China | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 815B | ||||||
| 641B | ||||||
| 352B | - | - | - | - | ||
| 314B | ||||||
| 303B |
